Repligen expands process analytics portfolio with DRS Daylight Solutions agreement
Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, today announced it has entered into a strategic partnership and exclusive license agreement with DRS Daylight Solutions to expand the use of mid-infrared (mid-IR) technology in the bioprocessing market.
Tony Hunt Emily Magee Repligen Corporation Analytics Technology Daylight Solutions Daylight Solutions Incsep
Source: news-medical.net